An expanded neonatal morbidity scale for premature infants

Area of Science:

• Neonatal Medicine
• Pediatric Health Outcomes
• Clinical Assessment Tools

Background:

• The original Neonatal Morbidity Scale (NMS) requires updates to reflect advances in neonatal care.
• Assessing morbidity in high-risk neonates post-discharge is crucial for monitoring health.
• Existing scales may not fully capture the complexities of neonatal health and social determinants.

Purpose of the Study:

• To revise and expand the Neonatal Morbidity Scale (NMS) into the Enhanced Neonatal Morbidity Scale (ENMS).
• To incorporate a social risk scale (SRS) into the revised instrument.
• To evaluate the validity and predictive ability of the ENMS-SRS for neonatal outcomes.

Main Methods:

• An inception cohort of 89 premature infants in an urban university hospital was studied.
• The revised scale (ENMS-SRS) was applied to assess neonatal morbidity.
• Linear and logistic regression analyses were used to determine concurrent validity and predictive accuracy.

Main Results:

• The ENMS-SRS demonstrated strong concurrent validity with birthweight (R2 = .54), gestational age (R2 = .50), and length of stay (R2 = .47).
• High inter-rater reliability of .95 was achieved for the ENMS.
• The scale showed predictive validity for specific outcomes within six months of discharge.

Conclusions:

• The Enhanced Neonatal Morbidity Scale (ENMS-SRS) is a valid tool for assessing premature infants in urban U.S. settings.
• The updated scale reflects contemporary patient profiles and incorporates social risk factors.
• The ENMS demonstrates predictive utility for short-term outcomes following special care unit discharge.